Literature DB >> 19022338

Androgen metabolism in adipose tissue: recent advances.

Karine Blouin1, Alain Veilleux, Van Luu-The, André Tchernof.   

Abstract

Androgens modulate adipocyte function and affect the size of adipose tissue compartments in humans. Aldo-keto reductase 1C (AKR1C) enzymes, especially AKR1C2 and AKR1C3, through local synthesis and inactivation of androgens, may be involved in the fine regulation of androgen availability in adipose tissue. This review article summarizes recent findings on androgen metabolism in adipose tissue. Primary culture models and whole tissue specimens of human adipose tissue obtained from the abdominal subcutaneous and intra-abdominal (omental) fat compartments were used in our studies. The non-aromatizable androgen dihydrotestosterone (DHT) inhibits adipocyte differentiation in subcutaneous and omental adipocytes in humans. This inhibitory effect is partially reversed by anti-androgens. Activity and mRNA expression of AKR1C1, 2 and 3 were detected in SC and OM adipose tissue, in men and women, with higher levels in the SC depot than the omental depot of both sexes. The abundance of AKR1C enzyme mRNAs was particularly elevated compared to other steroid-converting enzymes. Significant positive associations were observed between AKR1C enzyme mRNA levels or DHT inactivation rates and visceral fat accumulation as well as OM adipocyte size in women and in men, at least in the normal weight to moderately obese range. Mature adipocytes had significantly higher DHT inactivation rates compared to preadipocytes. Accordingly, adipocyte differentiation significantly increased AKR1C enzyme expression and DHT inactivation rates. Treatment of preadipocytes with dexamethasone alone led to significant increases in the formation of 5alpha-androstan-3alpha,17beta-diol. This stimulation was completely abolished by RU486, suggesting that androgen inactivation is stimulated by a glucocorticoid receptor-dependent mechanism. In conclusion, higher AKR1C activity and expression in mature adipocytes may explain the associations between these enzymes and obesity. We speculate that glucocorticoid-induced androgen inactivation could locally decrease the exposure of adipose cells to active androgens and partially remove their inhibitory effect on adipogenesis. We hypothesize that body fat distribution patterns likely emerge from the local adipose tissue balance between active androgens and glucocorticoids in each fat compartment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022338     DOI: 10.1016/j.mce.2008.10.035

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  37 in total

1.  Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.

Authors:  Carolyn L Westhoff; Anupama H Torgal; Elizabeth Rose Mayeda; Kelsey Petrie; Tiffany Thomas; Monica Dragoman; Serge Cremers
Journal:  Am J Obstet Gynecol       Date:  2012-04-28       Impact factor: 8.661

Review 2.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 3.  Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.

Authors:  Ronald S Swerdloff; Robert E Dudley; Stephanie T Page; Christina Wang; Wael A Salameh
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

4.  Label-free protein profiling of adipose-derived human stem cells under hyperosmotic treatment.

Authors:  Elizabeth S Oswald; Lewis M Brown; J Chloë Bulinski; Clark T Hung
Journal:  J Proteome Res       Date:  2011-06-14       Impact factor: 4.466

Review 5.  Adipocytes in skin health and disease.

Authors:  Guillermo Rivera-Gonzalez; Brett Shook; Valerie Horsley
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

6.  Bioactive androgens and glucuronidated androgen metabolites are associated with subcutaneous and ectopic skeletal muscle adiposity among older black men.

Authors:  Iva Miljkovic; Jane A Cauley; Amy S Dressen; Christopher L Gordon; Bret H Goodpaster; Lewis H Kuller; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Eric S Orwoll; Joseph M Zmuda
Journal:  Metabolism       Date:  2011-02-25       Impact factor: 8.694

7.  Androgens, body fat Distribution and Adipogenesis.

Authors:  Mouna Zerradi; Julie Dereumetz; Marie-Michèle Boulet; André Tchernof
Journal:  Curr Obes Rep       Date:  2014-12

8.  Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.

Authors:  Sean M Hartig; Bin He; Justin Y Newberg; Scott A Ochsner; David S Loose; Rainer B Lanz; Neil J McKenna; Benjamin M Buehrer; Sean E McGuire; Marco Marcelli; Michael A Mancini
Journal:  Chem Biol       Date:  2012-09-21

9.  Time-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis.

Authors:  Mari Lahnalampi; Merja Heinäniemi; Lasse Sinkkonen; Martin Wabitsch; Carsten Carlberg
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

Review 10.  Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.

Authors:  Bulent O Yildiz; Ricardo Azziz
Journal:  Fertil Steril       Date:  2009-04-25       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.